| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
32,396 |
25,036 |
$2.22M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,806 |
14,650 |
$898K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
31,957 |
24,042 |
$748K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
63,994 |
24,011 |
$507K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
31,633 |
23,775 |
$252K |
| 87634 |
|
13,042 |
10,625 |
$247K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,156 |
9,182 |
$137K |
| 99051 |
|
4,503 |
3,443 |
$54K |
| 87807 |
|
2,137 |
1,423 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
212 |
171 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
764 |
581 |
$8K |
| 87631 |
|
133 |
95 |
$5K |
| 81003 |
|
3,328 |
2,667 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
296 |
127 |
$3K |
| 87809 |
|
206 |
184 |
$2K |
| 81025 |
|
442 |
399 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39 |
28 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
11,630 |
9,035 |
$970.64 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
198 |
137 |
$822.74 |
| 90473 |
|
654 |
564 |
$429.46 |
| 3074F |
|
2,507 |
1,966 |
$263.02 |
| 3078F |
|
915 |
734 |
$259.29 |
| 86308 |
|
43 |
32 |
$229.68 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,365 |
1,031 |
$87.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
118 |
89 |
$63.06 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
92 |
60 |
$1.05 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$0.76 |
| 3079F |
|
479 |
389 |
$0.41 |
| 3075F |
|
32 |
25 |
$0.09 |
| J7510 |
Prednisolone oral, per 5 mg |
86 |
46 |
$0.00 |
| 99000 |
|
13 |
13 |
$0.00 |